The Cannigma

APRIL 12, 2023

In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Interestingly, unlike many formal clinical studies, participants in this data collection skewed female, with 196 women and 87 men. MoreBetter also hosts data collection studies.

Sleep 135

Sleep Data Tincture Research and Development 135

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Canna Care Docs

SEPTEMBER 18, 2020

Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication. Patients may purchase medical cannabis in oil-based preparations such as lozenges, capsules, and vape pens. Can a Qualifying Patient Grow Cannabis in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

FloridaMarijuana.net

JUNE 27, 2018

Participants in the study recorded their personal experience when using cannabis for their depression and other mental conditions such as anxiety and stress; scientists were able to use data collected from the app to analyze the results. Antidepressants alter the balance of chemicals in the brain to relieve symptoms of depression.

Treatment 100

Treatment Marijuana Data Conditions 100

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. An estimated 250 patients a month are said to be prescribed cannabis medicines through the NHS compared to over 2,500 in the UK’s private sector. Step In Right Direction.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Don’t have time to call? Find Out if You Qualify.

Data 114

Data Chronic Pain Sleep Patients 114

Cannabis Law Report

JUNE 22, 2021

2021 /CNW/ – Halo Collective Inc. (“Halo”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated multinational cannabis company, today announced that its board of directors has unanimously approved the reorganization (the “International Reorganization”) of its non-U.S. TORONTO , June 22,?2021

Collective 64

Collective Research and Development Cultivation Cannabis 64

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. The report further breaks down use by specific cultivars.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

Cannabis Law Report

JULY 21, 2021

Tryp will seek to identify a response in patients to the treatment to inform the design of a Phase 2b clinical trial for fibromyalgia that will use the company’s proprietary, psilocybin-based drug product, TRP-8803, that includes a novel formulation and unique method of delivery. San Diego, California–(Newsfile Corp.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

United Patients Group

MAY 17, 2023

collecting items related to trains). Recently, a pharmaceutical company has created a cannabis based isolate, meaning one cannabinoid, in this case CBD called Epidiolex which is available by prescription in all 50 states. Emotions and Behaviors Autism spectrum disorder (ASD) is a spectrum disorder that affects people in different ways.

Sleep 105

Sleep Cannabinoids Patients CBD 105

Canna Care Docs

NOVEMBER 4, 2024

Doctor is carefully examining a patient’s knee, providing personalized care and support. With a long history, it’s no surprise that patients still use medical cannabis to manage pain holistically. Patients dealing with chronic pain from numerous conditions are finding relief in cannabis. Since 2727 B.C.

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

Cannabis Law Report

AUGUST 3, 2021

Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. Medxtractor Corp. compound annual growth rate from $2.8

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

DECEMBER 22, 2019

On April 22, 2019, United Nations-based cannabis correspondent and global drug policy analyst Sara Brittany Somerset took advantage of our collective national climate focus to address the “ cannabis carbon footprint ” issue with her pertinent Earth Day Begs The Question: Is Cannabis Farming Sustainable?

Packaging 74

Packaging Seed-To-Sale Agriculture Environment 74

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Patients are unclear on what product to choose and healthcare providers don’t yet have the data to counsel on proper dosage.”. brands, including Lord Jones.

CBD 81

CBD Data Sleep Clinical Trials 81

Cannabis Law Report

SEPTEMBER 1, 2021

Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. He/ She is the point of contact for regulatory submission/ registration business partners.

Research and Development 105

Research and Development Supply Chain Compliance Compliance 105

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies. The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

APRIL 28, 2022

DEMECAN’s first cannabis shipment to the BfArM is ready for collection and includes more than 100 kg of cannabis flowers. High-quality cannabis flowers from DEMECAN’s German high-end facility are now available to patients. 2500 cannabis plants are now growing in its own flower rooms in Saxony.

Pharmaceutical 52

Pharmaceutical Cultivation Collective Patients 52

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. Ethypharm aspires to work closely with doctors and pharmacists to improve patients’ lives.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

Veriheal

JANUARY 25, 2022

Patients have expressed their disappointment with quality and pricing, citing the black market or other legal states as much better alternatives. This means they would have to be manufactured in a board-licensed and FDA-registered facility adhering to GMP protocol, just like pharmaceutical companies.

Hemp 98

Hemp Business CBD Seed-To-Sale 98

Cannabis Law Report

NOVEMBER 9, 2021

Akanda launches with two key assets, CanMart and Bophelo, bringing pharmaceutical grade cannabis from Africa to supply UK, European and other international markets. CanMart”) from Halo Collective Inc. (“Halo”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN). Bophelo”) and CanMart Ltd.

Collective 40

Collective Supply Chain Seed-To-Sale Events 40

Cannabis Law Report

MAY 8, 2022

I have an extensive background in healthcare and have worked in the community, aged care and palliative care sectors as well the corporate (pharmaceutical and insurance) sectors. I am the founder of the ECS Wellness Collective. Through my personal experiences, many patient interactions and my own education. WHAT MADE YOU STAND?

Education 98

Education Medicine Cannabinoids Programs 98

Veriheal

JANUARY 12, 2023

The law also permits the agricultural production of cannabis and hemp for industrial purposes, with a heavy emphasis on pharmaceutical crops. . This idyllic overseas collectivity of France is famous for its water-floating bungalow hotels, mountainous backdrops, and plunging waterfalls.

Medicine 97

Medicine Chronic Pain Consumption Cannabis 97

Cannabis Law Report

MARCH 22, 2020

Aurelius Data, a company dedicated to providing data around plant-based medicines, warned the public Tuesday that THC and COVID-19 don’t mix, based on what they know about how cannabinoids affect patients with influenza. Additional research is also needed to determine if THC is in fact harmful to coronavirus patients.

THC 59

THC Clinical Trials Data Consumption 59

Cannabis Law Report

JULY 19, 2021

Provide strategic recruitment that incorporates a diverse population (diversity is currently lacking in psychedelic research to date) with a database of 1 million+ patients in Canada and 15 million+ globally. MONTREAL & CALGARY, Alberta & TORONTO–(BUSINESS WIRE)– #biotechnology –Knowde Group Inc. ,

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Otherside Farms

JANUARY 25, 2019

Although this might actually be what it takes to push this legislation through on the federal level, it could also mean that the patients who need this all-natural medicine the most will be the ones who can least afford it. Only 730,000 people are authorized MMJ patients as of 2011.

Marijuana 68

Marijuana Strains Medicine Chronic Pain 68

Cannabis Law Report

JULY 28, 2021

Based on these promising findings, PharmaDrug reiterates that it remains committed to the clinical development of PD-001 for the treatment of patients suffering from esophageal cancer. ” Next Steps.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JULY 7, 2021

as the Company’s contract research division also places the company at the forefront of premium clinical research based on its 23-year history and extensive experience in pharmaceuticals, cannabis, and the emerging psychedelic medicine industries. On behalf of: KETAMINE ONE. ” Adam Deffett ” Adam Deffett, Interim CEO.

Research and Development 98

Research and Development Treatment Therapy Banking 98

CannaTech

APRIL 1, 2019

The application of ethnobotanical principles with advanced analytical and scientific methods accelerates cannabis-based discovery – to the benefit of patients worldwide. Eybna studies cannabis phenotypes to develop complimentary secondary metabolite products enhancing therapeutic potential. What is ethnobotany?

Research and Development 60

Research and Development Terpenes Data Strains 60

Cannabis Law Report

OCTOBER 5, 2021

“This scientific and commercial excitement rests on research showing that psychedelics can supercharge mental health treatment for PTSD, depression, anxiety, addiction, and other chronic ailments of the mind, enabling patients to dive deep, confront their traumas and — a rarity for mental illnesses — return healed,” the article reads.

Therapy 52

Therapy Pharmaceutical Collective Treatment 52